Investigation strategy in the diagnosis of Cushing's syndrome

Canadian Journal of Diabetes

Volumn 27, Issue 1, 2003, Pages 52-61

  Beauregard, Catherine ^a   Lacroix, André ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHORIONIC GONADOTROPIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESMOPRESSIN; DEXAMETHASONE; GASTRIC INHIBITORY POLYPEPTIDE; HYDROCORTISONE; LUTEINIZING HORMONE; SEROTONIN; VASOPRESSIN;

ADRENAL HYPERPLASIA; ADRENALECTOMY; BLOOD ANALYSIS; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIABETES MELLITUS; DISEASE SEVERITY; ECTOPIC CORTICOTROPIN PRODUCTION; EVALUATION; HUMAN; HYPOPHYSIS ADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

EID: 0042971425     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Nieman LK. Cushing's syndrome. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, PA: WB Saunders; 2001:1691-1720.
2. Orth DN, Kovacs WJ. The adrenal cortex. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia, PA: WB Saunders; 1998:517-664.
3. Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex. Nat Genet. 2000;26:89-92.
4. Weinstein LS, Shenker A, Gejman PV, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome, N Engl J Med. 1991;325:1688-1695.
5. Lacroix A, N'Diaye N, Tremblay J, Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev. 2001;22:75-110.
6. Boyle PJ. Cushing's disease, glucocorticoid excess, glucocorticoid deficiency and diabetes. Diabetes Rev. 1993;1:301-308.
7. Leibowitz G, Tsur A, Chayen SD, et al. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf). 1996;44:717-722.
8. Tayek JA, Katz J. Glucose production, recycling, Cori cycle, and gluconeogenesis in humans: relationship to serum cortisol. Am J Physiol. 1997;272:E476-E484.
9. Weinstein SP, Wilson CM, Pritsker A, Cushman SW. Dexamethasone inhibits insulin-stimulated recruitment of GLUT4 to the cell surface in rat skeletal muscle. Metabolism. 1998;47:3-6.
10. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev. 1998;19:647-672.
11. Newell-Price J, Trainer P, Perry L, et al. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf). 1995;43:545-550.
12. Papanicolaou DA, Yanovski JA, Cutler GB Jr, et al. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab. 1998;83:1163-1167.
13. Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab. 1998;83:2681-2686.
14. Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA. 1993;269:2232-2238.
15. Raff H, Findling JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem. 1989;35:596-600.
16. Howlett TA, Drury PL, Perry L, et al. Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf). 1986;24:699-713.
17. Nieman LK, Chrousos GP, Oldfield EH, et al. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Ann Intern Med. 1986;105:862-867.
18. Tyrrell JB, Findling JW, Aron DC, et al. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med. 1986;104:180-186.
19. Abou Samra AB, Dechaud H, Estour B, et al. Beta-lipotropin and cortisol responses to an intravenous infusion dexamethasone suppression test in Cushing's syndrome and obesity. J Clin Endocrinol Metab. 1985;61:116-119.
20. Leclerc I, Bolté E, Lacroix A. Intravenous dexamethasone suppression test (DST) for the differential diagnosis of Cushing's syndrome (CS) [abstract]. Presented at the 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, June 11-14, 1997:2-75.
21. Croughs RJ, Docter R, de Jong FH. Comparison of oral and intravenous dexamethasone suppression tests in the differential diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh). 1973;72:54-62.
22. Biemond P, de Jong FH, Lamberts SW. Continuous dexamethasone infusion for seven hours in patients with the Cushing syndrome, A superior differential diagnostic test. Ann Intern Med. 1990;112:738-742.
23. Atkinson AB, McAteer EJ, Hadden DR, et al. A weight-related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing's syndrome. Acta Endocrinol (Copenh). 1989;120:753-759.
24. al-Saadi N, Diederich S, Oelkers W. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf). 1998;48:45-51.
25. Stratakis CA, Sarlis N, Kirschner LS, et al. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med. 1999;131:585-591.
26. Nieman LK, Oldfield EH, Wesley R, et al. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 1993;77:1308-1312.
27. Kaye TB, Crapo L. The Cushing syndrome: an update on diagnostic tests. Ann Intern Med. 1990;112:434-444.
28. Boscaro M, Barzon L, Sonino N. The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings. Arch Intern Med. 2000;160:3045-3053.
29. Newell-Price J, Perry L, Medbak S, et al. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab. 1997;82:176-181.
30. Hall WA, Luciano MG, Doppman JL, et al. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med. 1994;120:817-820.
31. Hoh CK, Schiepers C, Seltzer MA, et al. PET in oncology: will it replace the other modalities? Semin Nucl Med. 1997;27:94-106.
32. de Herder WW, Lamberts SWJ. Tumor localization - the ectopic ACTH syndrome [editorial]. J Clin Endocrinol Metab. 1999;84:1184-1185.
33. Tabarin A, Valli N, Chanson P, et al. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 1999;84: 1193-1202.
34. 111In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab. 1999;84:1186-1192.
35. Oldfield EH, Doppman JL, Nieman LK, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med. 1991;325:897-905.
36. Wiggam MI, Heancy AP, McIlrath EM, et al. Bilateral inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome: a comparison with other diagnostic tests. J Clin Endocrinol Metab. 2000;85:1525-1532.
37. Kaltsas GA, Giannulis MG, Newell-Price JDC, et al. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 1999;84:487-492.
38. Hamet P, Larochelle P, Franks DJ, et al. Cushing syndrome with food-dependent periodic hormonogenesis. Clin Invest Med. 1987;10:530-533.
39. Lacroix A, Bolté E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N Engl J Med. 1992;327:974-980.
40. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med. 1992;327:981-986.
41. N'Diaye N, Tremblay I, Hamet P, et al. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome. J CIin EndocrinoI Metab. 1998;83:2781-2785.
42. Arnaldi G, Gasc J-M, de Keyzer Y, et al. Variable expression of the VI vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Clin Endocrinol Metab. 1998;83:2029-2035.
43. Bourdeau I, D'Amour P, Hamet P, et al. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. J Clin Endocrinol Metab. 2001;86:5534-5540.
44. Lacroix A, Tremblay J, Rousseau G, et al. Propranolol therapy for ectopic B-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med. 1997;337:1429-1434.
45. Mircescu H, Jilwan J, N'Diaye N, et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J Clin EndocrinoI Metab. 2000;85:3531-3536.
46. Lacroix A, Hamet P, Boutin J-M. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N Engl J Med. 1999;341:1577-1581.
47. Lefebvre H, Contesse V, Delarue C, et al. Serotonergic regulation of adrenocortical function. Horrn Metab Res. 1998;30:398-403.
48. Nakamura Y, Son Y, Kohno Y, et al. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin 11. Endocrine. 2001;15:57-61.
49. Lacroix A, Mircescu H, Hamet P. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. Endocrinologist. 1999;9:9-15.